Century Therapeutics, Inc. (IPSC)
Stock Price: $22.83 USD
2.83 (14.15%)
Updated Jun 18, 2021 4:00 PM EDT - Market closed
After-hours: $22.70 -0.13 (-0.57%) Jun 18, 6:51 PM
| Market Cap | 1.20B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -62.25M |
| Shares Out | 52.55M |
| EPS (ttm) | -1.18 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | June 18 |
| Last Price | $22.83 |
| IPO Price | $20.00 |
| Change ($) | 2.83 |
| Change (%) | 14.15% |
| Day's Open | 19.50 |
| Day's Range | 18.93 - 22.83 |
| Day's Volume | 2,500,165 |
| 52-Week Range | 18.93 - 22.83 |
News
Century Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.
About IPSC
Century Therapeutics is an innovative biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. We have created a comprehensive allogeneic cell therapy platform that allows us to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, our ... [Read more...]
| Industry Biological Products | IPO Date Jun 18, 2021 |
| CEO Osvaldo Flores, Ph.D. | Employees 107 |
| Stock Exchange NASDAQ | Ticker Symbol IPSC |